Prostate

Fibroblast as a critical stromal cell type determining prognosis in prostate cancer.

Blom S, Erickson A, Östman A, ..., Kallioniemi O, Pellinen T

Prostate 79 (13) 1505-1513 [2019-09-00; online 2019-07-03]

Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram.

Majera D, Skrott Z, Bouchal J, ..., Mistrik M, Bartek J

Prostate 79 (4) 352-362 [2019-03-00; online 2018-11-29]